The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary & Animal Vaccines Market Research Report 2025
Synopsis
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology.
The global Veterinary & Animal Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 11%.
This report aims to provide a comprehensive presentation of the global market for Veterinary & Animal Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary & Animal Vaccines.
Report Scope
The Veterinary & Animal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary & Animal Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary & Animal Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester
Hipra
Idt Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Segment by Application
Hospitals and Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary & Animal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology.
The global Veterinary & Animal Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 11%.
This report aims to provide a comprehensive presentation of the global market for Veterinary & Animal Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary & Animal Vaccines.
Report Scope
The Veterinary & Animal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary & Animal Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary & Animal Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester
Hipra
Idt Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Segment by Application
Hospitals and Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary & Animal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary & Animal Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary & Animal Vaccines
1.2 Veterinary & Animal Vaccines Segment by Type
1.2.1 Global Veterinary & Animal Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Other Vaccines
1.3 Veterinary & Animal Vaccines Segment by Application
1.3.1 Global Veterinary & Animal Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Veterinary & Animal Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary & Animal Vaccines Revenue 2019-2030
1.4.2 Global Veterinary & Animal Vaccines Sales 2019-2030
1.4.3 Global Veterinary & Animal Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary & Animal Vaccines Market Competition by Manufacturers
2.1 Global Veterinary & Animal Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary & Animal Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary & Animal Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary & Animal Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary & Animal Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary & Animal Vaccines, Product Type & Application
2.7 Veterinary & Animal Vaccines Market Competitive Situation and Trends
2.7.1 Veterinary & Animal Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary & Animal Vaccines Players Market Share by Revenue
2.7.3 Global Veterinary & Animal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary & Animal Vaccines Retrospective Market Scenario by Region
3.1 Global Veterinary & Animal Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary & Animal Vaccines Global Veterinary & Animal Vaccines Sales by Region: 2019-2030
3.2.1 Global Veterinary & Animal Vaccines Sales by Region: 2019-2024
3.2.2 Global Veterinary & Animal Vaccines Sales by Region: 2025-2030
3.3 Global Veterinary & Animal Vaccines Global Veterinary & Animal Vaccines Revenue by Region: 2019-2030
3.3.1 Global Veterinary & Animal Vaccines Revenue by Region: 2019-2024
3.3.2 Global Veterinary & Animal Vaccines Revenue by Region: 2025-2030
3.4 North America Veterinary & Animal Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary & Animal Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary & Animal Vaccines Sales by Country (2019-2030)
3.4.3 North America Veterinary & Animal Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary & Animal Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary & Animal Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary & Animal Vaccines Sales by Country (2019-2030)
3.5.3 Europe Veterinary & Animal Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary & Animal Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary & Animal Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary & Animal Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary & Animal Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary & Animal Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary & Animal Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary & Animal Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Veterinary & Animal Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary & Animal Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary & Animal Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary & Animal Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary & Animal Vaccines Sales by Type (2019-2030)
4.1.1 Global Veterinary & Animal Vaccines Sales by Type (2019-2024)
4.1.2 Global Veterinary & Animal Vaccines Sales by Type (2025-2030)
4.1.3 Global Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Veterinary & Animal Vaccines Revenue by Type (2019-2030)
4.2.1 Global Veterinary & Animal Vaccines Revenue by Type (2019-2024)
4.2.2 Global Veterinary & Animal Vaccines Revenue by Type (2025-2030)
4.2.3 Global Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary & Animal Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary & Animal Vaccines Sales by Application (2019-2030)
5.1.1 Global Veterinary & Animal Vaccines Sales by Application (2019-2024)
5.1.2 Global Veterinary & Animal Vaccines Sales by Application (2025-2030)
5.1.3 Global Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Veterinary & Animal Vaccines Revenue by Application (2019-2030)
5.2.1 Global Veterinary & Animal Vaccines Revenue by Application (2019-2024)
5.2.2 Global Veterinary & Animal Vaccines Revenue by Application (2025-2030)
5.2.3 Global Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary & Animal Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Veterinary & Animal Vaccines Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Animal Health Veterinary & Animal Vaccines Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Veterinary & Animal Vaccines Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Veterinary & Animal Vaccines Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vetoquinol Veterinary & Animal Vaccines Product Portfolio
6.6.5 Vetoquinol Recent Developments/Updates
6.7 Phibro Animal Health
6.6.1 Phibro Animal Health Corporation Information
6.6.2 Phibro Animal Health Description and Business Overview
6.6.3 Phibro Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio
6.7.5 Phibro Animal Health Recent Developments/Updates
6.8 Hester
6.8.1 Hester Corporation Information
6.8.2 Hester Description and Business Overview
6.8.3 Hester Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hester Veterinary & Animal Vaccines Product Portfolio
6.8.5 Hester Recent Developments/Updates
6.9 Hipra
6.9.1 Hipra Corporation Information
6.9.2 Hipra Description and Business Overview
6.9.3 Hipra Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hipra Veterinary & Animal Vaccines Product Portfolio
6.9.5 Hipra Recent Developments/Updates
6.10 Idt Biologika
6.10.1 Idt Biologika Corporation Information
6.10.2 Idt Biologika Description and Business Overview
6.10.3 Idt Biologika Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Idt Biologika Veterinary & Animal Vaccines Product Portfolio
6.10.5 Idt Biologika Recent Developments/Updates
6.11 Biogenesis Bago
6.11.1 Biogenesis Bago Corporation Information
6.11.2 Biogenesis Bago Veterinary & Animal Vaccines Description and Business Overview
6.11.3 Biogenesis Bago Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio
6.11.5 Biogenesis Bago Recent Developments/Updates
6.12 Tianjin Ringpu
6.12.1 Tianjin Ringpu Corporation Information
6.12.2 Tianjin Ringpu Veterinary & Animal Vaccines Description and Business Overview
6.12.3 Tianjin Ringpu Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio
6.12.5 Tianjin Ringpu Recent Developments/Updates
6.13 China Animal Husbandry
6.13.1 China Animal Husbandry Corporation Information
6.13.2 China Animal Husbandry Veterinary & Animal Vaccines Description and Business Overview
6.13.3 China Animal Husbandry Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio
6.13.5 China Animal Husbandry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary & Animal Vaccines Industry Chain Analysis
7.2 Veterinary & Animal Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary & Animal Vaccines Production Mode & Process
7.4 Veterinary & Animal Vaccines Sales and Marketing
7.4.1 Veterinary & Animal Vaccines Sales Channels
7.4.2 Veterinary & Animal Vaccines Distributors
7.5 Veterinary & Animal Vaccines Customers
8 Veterinary & Animal Vaccines Market Dynamics
8.1 Veterinary & Animal Vaccines Industry Trends
8.2 Veterinary & Animal Vaccines Market Drivers
8.3 Veterinary & Animal Vaccines Market Challenges
8.4 Veterinary & Animal Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
